pegvaliase: Clinical Trials

4 trials of pegvaliase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Active not recruiting 1

Follow pegvaliase: new trials by email Literature Review of pegvaliase trials Research Report on pegvaliase

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
Pegvaliase, Diet Only - Phenylketonuria (PKU)
Phase 3Active not recruitingBioMarin Pharmaceutical552022-06-172026-07-21
Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
Pegvaliase - Phenylketonuria (PKU)
Phase 3CompletedBioMarin Pharmaceutical372018-09-132022-02-17
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
BMN165 20mg/day, BMN165 40mg/day, Placebo - Phenylketonuria (PKU)
Phase 3CompletedBioMarin Pharmaceutical2152013-07-292021-05-21
An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165
BMN 165 - Phenylketonuria
Phase 3CompletedBioMarin Pharmaceutical2612013-05-012019-02-26

Conditions studied

Phenylketonurias (4)

Sponsors

BioMarin Pharmaceutical (4)

Countries

United States (4)  ·  Germany (1)

Top investigators

Markus Merilainen, MD (1)

Results publications

PMID 40411344, PMID 34826353